Future MS care: a consensus statement of the MS in the 21st Century Steering Group

The effect of social support on the quality of life of patients with multiple sclerosis

(2012) David Castro Costa et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

Individualizing treatment goals and interventions for people with MS

(2012) Gavin Giovannoni et al.   CURRENT OPINION IN NEUROLOGY

Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects

(2012) Jeffrey A Cohen et al.   LANCET NEUROLOGY

Global pharmaceutical development and access: critical issues of ethics and equity

(2012) Agustín Lage Dávila   MEDICC Review

Improving patient–physician dialog: commentary on the results of the MS Choices survey

(2012) Alessandra Lugaresi et al.   Patient Preference and Adherence

Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes

(2011) Alasdair J Coles et al.   LANCET NEUROLOGY

Evolution of multiple sclerosis treatment: next generation therapies meet next generation efficacy criteria

(2011) Hans-Peter Hartung et al.   LANCET NEUROLOGY

Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis

(2011) Gavin Giovannoni et al.   LANCET NEUROLOGY

Cost of multiple sclerosis in the Czech Republic: The COMS study

(2011) J Blahova Dusankova et al.   Multiple Sclerosis Journal

Implementation of a patient education program on multiple sclerosis relapse management

(2011) Sascha Köpke et al.   PATIENT EDUCATION AND COUNSELING

Process R&D under the magnifying glass: Organization, business model, challenges, and scientific context

(2010) Hans-Jürgen Federsel   BIOORGANIC & MEDICINAL CHEMISTRY

Development and pilot phase of a European MS register

(2010) Peter Flachenecker et al.   JOURNAL OF NEUROLOGY

Decisions on multiple sclerosis immunotherapy: New treatment complexities urge patient engagement

(2010) Christoph Heesen et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care

(2010) A. Solari et al.   Multiple Sclerosis Journal

Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis

(2010) Maria Pia Sormani et al.   Multiple Sclerosis Journal

Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs

(2010) MP Sormani et al.   Multiple Sclerosis Journal

Diseño de una vía clínica para la atención a los pacientes con esclerosis múltiple

(2010) C. Oreja-Guevara et al.   NEUROLOGIA

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

(2010) Gavin Giovannoni et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

(2009) Eva Havrdova et al.   LANCET NEUROLOGY

The future of multiple sclerosis therapy☆

(2009) Bernd C. Kieseier et al.   PHARMACOLOGICAL RESEARCH

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

(2008)   NEW ENGLAND JOURNAL OF MEDICINE